Clinical Cancer Research
-
Breast cancer study may help predict treatment response
Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat. Read MoreFeb 27, 2020
-
Improving therapies for GI tumors
A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target. Read MoreFeb 20, 2017
-
Drug combos for glioblastoma
Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment. Read MoreMay 3, 2016
-
Five candidates sought for Runyon Cancer Clinical Investigator Award
Vanderbilt University may nominate five candidates for the 2016 Damon Runyon Cancer Research Foundation Clinical Investigator Award. Read MoreNov 13, 2015
-
PET probe detects dying tumor cells
A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine. Read MoreMay 8, 2014
-
New drugs a good BET for brain cancer
A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. Read MoreMar 20, 2013
-
New drug mutes more melanomas
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies. Read MoreApr 26, 2012
-
Factor sensitizes cancer to radiation
Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read MoreApr 6, 2012